Study title: A randomised, multicenter, double-blind, placebo controlled , group comparative study of TILADE (Necrodomil Sodium) 4 mg QID vs. Placebo administrated via metered dose inhaler (MDI) in the treatment of children with asthma which is exacerbated by ragweed pollen - Don Bukstein et al. - 05/12/1995
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NEDOCROMIL | |||||
ATC code: S01GX04 | |||||
Document link: | |||||
Document date: 2013-01-24 | |||||
Study number: CR 2340/1 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |